久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Sandoz launches SYMJEPI in the US americanpharmaceuticalreview
    January 21, 2019
    Sandoz announced the US market introduction of SYMJEPI (epinephrine) 0.3 mg Injection for the emergency treatment of allergic reactions (Type 1), including anaphylaxis.....
  • Sandoz Announces FDA Approval of Pediatric Dose of Symjepi americanpharmaceuticalreview
    September 29, 2018
    Sandoz announced the US Food and Drug Administration (FDA) has approved Symjepi (epinephrine) 0.15 mg Injection for the emergency treatment of allergic reactions in children.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service